CureVac

With failed COVID shot still dragging on earnings, CureVac tries to turn page to next-gen mRNA tech
Fierce Biotech
Wed, 05/25/22 - 11:32 pm
CureVac
COVID-19
vaccines
earnings
Opportunities arise for once-spurned partners
EP Vantage
Fri, 05/13/22 - 10:34 am
Pfizer
Biohaven
licensing
M&A
Aurinia
Bristol Myers Squibb
AbbVie
Alector
Arcus Biosciences
Biogen
Blueprint Medicines
CureVac
Gilead Sciences
GSK
Incyte
MorphoSys
Roche
Nestle
SAGE Therapeutics
Sarepta Therapeutics
Seres Therapeutics
Syndax
GlaxoSmithKline, CureVac and BioNTech clinch German pandemic preparedness contracts
Fierce Pharma
Mon, 04/11/22 - 10:33 am
GSK
BioNTech
CureVac
Germany
pandemic
CureVac and GSK try again with COVID-19 vaccine
Pharmaforum
Thu, 03/31/22 - 10:21 am
GSK
CureVac
vaccines
COVID-19
MRNA
BioNTech, CureVac part of $3.14B deal to bolster German vaccine capacity through 2029: report
Fierce Pharma
Thu, 03/17/22 - 10:20 am
Germany
BioNTech
CureVac
GSK
vaccines
CureVac Publishes in Nature Preclinical Data of Second-Generation COVID-19 Candidate, CV2CoV, Demonstrating Comparable Antibody Levels to Licensed mRNA Vaccine
Yahoo Finance
Thu, 11/18/21 - 10:36 am
CureVac
MRNA
vaccines
COVID-19
End-of-Year Restructuring Means Layoffs for These Companies
BioSpace
Tue, 11/16/21 - 11:57 am
restructuring
Rigel Pharmaceuticals
Zymergen
Esperion Therapeutics
Amarin
Theravance
Sanofi
Acorda Therapeutics
CureVac
Ziopharm Oncology
Bayer breaks off Covid-19 vaccine manufacturing pact as CureVac pivots to second-gen work — report
Endpoints
Fri, 10/15/21 - 10:57 am
CureVac
Bayer
vaccines
COVID-19
MRNA
drug manufacturing
CureVac drops COVID-19 vaccine candidate; shifts focus to second-generation mRNA program
Biopharma Reporter
Tue, 10/12/21 - 11:06 am
CureVac
vaccines
COVID-19
MRNA
GSK
CureVac Adjusts to Vaccine Demand by Reducing European mRNA Manufacturing Network
BioSpace
Tue, 09/14/21 - 10:39 pm
CureVac
MRNA
Europe
vaccines
drug manufacturing
Could CureVac's Canceled Deal Spell Trouble for Other mRNA Cancer Vaccines?
Motley Fool
Fri, 08/27/21 - 10:54 am
CureVac
Boehringer Ingelheim
MRNA
lung cancer
vaccines
Moderna Therapeutics
BioNTech
GSK, CureVac's next-gen COVID-19 vaccine shows promise in monkey trial
Reuters
Mon, 08/16/21 - 10:22 pm
GSK
CureVac
MRNA
COVID-19
vaccines
The 7-year itch? Boehringer culls $600M cancer pact with CureVac, heaping more woe to the biotech
Fierce Biotech
Mon, 08/16/21 - 12:09 pm
CureVac
MRNA
Boehringer Ingelheim
COVID-19
vaccines
CureVac to ‘plow forward’ with Covid vaccine despite disappointing results
CNBC
Thu, 07/1/21 - 11:00 am
CureVac
COVID-19
vaccines
clinical trials
How Pfizer and Moderna Could Profit Big-Time From AstraZeneca's and CureVac's Challenges
Motley Fool
Wed, 06/23/21 - 10:40 am
Pfizer
Moderna Therapeutics
AstraZeneca
CureVac
vaccines
COVID-19
12 Words From CureVac's CEO That Could Mean Billions for Moderna and Pfizer
Motley Fool
Fri, 06/18/21 - 10:57 am
MRNA
vaccines
COVID-19
CureVac
Moderna Therapeutics
Pfizer
clinical trials
GSK, Bayer stand by CureVac following 'disappointing' COVID-19 vaccine trial flop
Fierce Pharma
Thu, 06/17/21 - 10:44 pm
CureVac
Bayer
GSK
vaccines
COVID19
CureVac's first-gen COVID-19 vaccine misses the mark with 47% efficacy, as share price halves in after-hours trading
Fierce Biotech
Wed, 06/16/21 - 11:21 pm
CureVac
MRNA
vaccines
COVID-19
CureVac's Potential Has Wall Street Sending Mixed Signals
Motley Fool
Mon, 04/26/21 - 11:17 pm
CureVac
vaccines
COVID-19
Novartis inks 3rd COVID-19 production pact, this time for Roche's arthritis med Actemra
Fierce Pharma
Thu, 04/15/21 - 11:21 am
Novartis
COVID-19
Pfizer
BioNTech
CureVac
Roche
API
Actemra

Pages